Background {#Sec1}
==========

Antiretroviral therapy (ART) is now recommended worldwide for all people living with HIV (PLHIV), regardless of their CD4 cell count \[[@CR1]\]. However, barriers to ART access for PLHIV do exist, with important differences among countries, especially according to socio-economic levels and organization models of national healthcare systems \[[@CR2]\]. These disparities can affect the probability of reaching the "90--90-90" target fixed by UNAIDS for 2030 (90% diagnosed individuals of all PLHIV, 90% treated patients, and 90% PLHIV achieving viral suppression) \[[@CR3]\].

Even in high income countries, social determinants are known to be a driving force of health inequalities \[[@CR4]\]. In the setting of HIV infection, demographic and socioeconomic factors can limit the access to testing, treatment, and retention in care and, consequently, reduce survival of PLHIV \[[@CR5]\]. Entering the era of universal ART for all HIV people living with HIV, we can hypothesize that these factors could have an even greater impact on disparities in ART access compared to past years.

In 2015, the proportion of people newly diagnosed with HIV and presenting with \< 200 cell/μL CD4 was 36.6% in Italy, whereas proportion of people with CD4 \< 350 cell/μL was 54.5% \[[@CR6]\]. In a previous study from the ICONA (Italian Cohort Naïve Antiretrovirals) cohort, among socio-demographic factors, migrant status was already demonstrated to be associated with barriers to ART initiation and with increased risk of treatment failure compared to natives \[[@CR7]\]. However, other social or behavioral determinants, including gender \[[@CR8], [@CR9]\], poor education \[[@CR10], [@CR11]\], unemployment \[[@CR12]\], social exclusion within special population groups, e.g. people who inject drugs (PWID), need to be considered \[[@CR13]\].

Moreover, also in people accessing ART and adhering to therapy, lifestyle differences can affect chances to respond to ART, occurrence of side effects and co-morbidities in PLHIV \[[@CR14]\].

Aim of our study was to determine if social determinants influence ART access, outcome and retention in care of PLHIV in spite of a context of public healthcare. The knowledge of factors which define the "social vulnerability" can allow to allocate resources and plan for interventions in order to reduce disparities which impact survival of persons living with HIV.

Methods {#Sec2}
=======

The ICONA Foundation Study is an observational cohort of people living with HIV who are antiretroviral naïve at the time of enrolment. This cohort was set up in January 1997 and currently consists of over 14,000 patients from 50 Italian infectious disease reference units. Demographic and socio-behavioral data, initiation and discontinuation dates of each antiretroviral drug, HIV-viral load and CD4 cell count every 3--6 months, AIDS defining diseases according to Centers for Disease Control and Prevention (CDC) criteria as well as non-HIV related diseases and death are recorded for all enrolled participants. Further details are available at <http://www.fondazioneicona.org>/.

In the present study, all ART naïve PLHIV of Italian nationality enrolled in the ICONA Cohort from 2002 to 2016 were included. The following socio-demographic characteristics were retrieved and analyzed for their potential association with the study endpoints: age, gender (male, female), risk factor for HIV infection \[heterosexuals (HS), men who have sex with men (MSM), people who inject drugs (PWID)\], educational level, occupational status and residency area. Taking into account the structure of the Italian education system, and according to the UNESCO/International Standard Classification of Education standard classification (ISCED) \[[@CR15]\], the educational level was categorized into four categories: primary school (corresponding to ISCED 0); junior secondary school (ISCED 1); high secondary school (ISCED 2--3); tertiary school (university and similar) (ISCED ≥4). The occupational status was classified into seven categories as follows: full-time worker, temporary employed, self employed, unemployed, student, retired, housewife (defined as women ~~only~~ managing household affairs without having paid employment). The residency area was categorized in Northern, Central and Southern Italy.

Patients who did not attend visits for ≥18 months were defined as lost to follow-up.

Statistical analysis {#Sec3}
--------------------

The study time was divided into 3--5 years periods: 2002--2006; 2007--2011; 2012--2016, in order to compare different ART treatment period, according to guidelines changes and progressive availability of new antiretroviral drugs. Patients' characteristics were compared according to time period using Chi square test for trend for categorical variables and Kruskal Wallis test for continuous parameters.

Three different end-points were evaluated:probability of ART initiation from the first positive anti-HIV test;virological response defined as first HIV-RNA \< 50 cp/mL after therapy start;first ART regimen discontinuation for any causes.

For the evaluation of the endpoints (b) and (c) only patients with ≥1 year of follow-up were included.

The association of socio-demographic characteristics (age, sex, risk factor for HIV infection, educational level, occupational status and residency area, smoking habit) and clinical parameters (CDC stage, CD4 and HIV RNA value and pregnancy) with three end-points were evaluated by Cox regression analysis. 1-year probability was evaluated by Kaplan Meier method and log-rank test was used to compare survival curves.

Results {#Sec4}
=======

Baseline patient characteristics {#Sec5}
--------------------------------

A total of 8023 HIV-positive patients (82% males, median age at first positive anti-HIV test: 36 years, IQR: 29--44) were included in the ICONA observational database in the period 2002--2016, whose characteristics are shown in Table [1](#Tab1){ref-type="table"}**,** overall and according to the three different study periods. Median age at time of enrolment, proportion of males and MSM increased over time. Moreover, a growing number of people with high secondary and tertiary level of education but a decreasing number of full employed workers was observed in last period (2012--2016). The percentage of pre-treatment AIDS events and very late presenter patients (\< 200 CD4/μl) decreased passing from the first to the last period from 13 and 26% to 7 and 17%, respectively.Table 1Socio-demographic characteristics of patients according to years of starting cART or year of last observationOverall\
*N* = 80232002--2006\
*N* = 15432007--2011\
*N* = 21662012--2016\
*N* = 4314*p*Gender, n (%) Female1434 (17.9%)453 (29.4%)368 (17.0%)613 (14.2%)\< 0.001 Male6589 (82.1%)1090 (70.6%)1798 (83.0%)3701 (85.8%)Age at first positive anti-HIV test, n (%) \< 302582 (32.2%)682 (44.2%)637 (29.5%)1263 (29.3%)\< 0.001 30--402646 (33.0%)521 (33.8%)742 (34.4%)1383 (32.1%) 40--501709 (21.3%)221 (14.3%)475 (22.0%)1013 (23.5%) \> 501079 (13.5%)119 (7.7%)305 (14.1%)655 (15.2%)Mode of HIV transmission, n (%) HS2773 (34.6%)590 (38.2%)816 (37.7%)1367 (31.7%)\< 0.001 PWID1131 (14.1%)509 (33.0%)265 (12.2%)357 (8.3%) MSM3528 (44.0%)342 (22.2%)942 (43.5%)2244 (52.0%) other/unknown591 (7.4%)102 (6.6%)143 (6.6%)346 (8.0%)Education Elementary school362 (4.5%)162 (10.5%)99 (4.6%)101 (2.3%)\< 0.001 Junior high school1803 (22.5%)596 (38.6%)528 (24.4%)679 (15.7%) High school2576 (32.1%)423 (27.4%)708 (32.7%)1445 (33.5%) University920 (11.5%)101 (6.6%)217 (10.0%)602 (14.0%) Missing data2362 (29.4%)261 (16.9%)614 (28.4%)1487 (34.5%)Employement Full time worker3575 (44.6%)703 (45.6%)1100 (50.8%)1772 (41.1%)\< 0.001 Unemployed910 (11.3%)307 (19.9%)217 (10.0%)386 (9.0%) Self employed1231 (15.3%)265 (17.2%)304 (14.0%)662 (15.4%) Temporary employed192 (2.4%)75 (4.9%)45 (2.1%)72 (1.7%) Student296 (3.7%)29 (1.9%)75 (3.5%)192 (4.5%) Retired256 (3.2%)40 (2.6%)96 (4.4%)120 (2.8%) Housewife233 (2.9%)103 (6.7%)72 (3.3%)58 (1.3%) Other/unknown204 (2.5%)18 (1.2%)40 (1.9%)146 (3.4%) Missing data1126 (14.0%)3 (0.2%)217 (10.0%)906 (21.0%)Residency area Northern Italy4540 (56.6%)763 (49.5%)1226 (56.6%)2551 (59.1%)\< 0.001 Central Italy2678 (33.4%)517 (33.5%)769 (35.5%)1392 (32.3%) Southern Italy805 (10.0%)263 (17.0%)171 (7.9%)371 (8.6%)Smokers No3589 (44.7%532 (34.5%)1040 (48.0%)2017 (46.8%)\< 0.001 Yes3636 (45.3%)787 (51.0%)990 (45.7%)1859 (43.1%) Not known798 (10.0%)224 (14.5%)136 (6.3%)438 (10.2%)CDC stage C714 (8.9%)199 (12.9%)219 (10.1%)296 (6.9%)\< 0.001 A/B7309 (91.1%)1344 (87.1%)1947 (89.9%)4018 (93.1%)Pre treatment CD4 cell/mmc \< =2001630 (20.3%)404 (26.2%)508 (23.5%)718 (16.6%)\< 0.001 201--3501952 (24.3%)516 (33.4%)699 (32.3%)737 (17.1%) 351--5001761 (22.0%)251 (16.3%)473 (21.8%)1037 (24.0%) 500-max1913 (23.8%)308 (20.0%)291 (13.4%)1314 (30.5%) Missing data767 (9.6%)64 (4.2%)195 (9.0%)508 (11.8%)Pre treatment log10 HIV RNA \< 41844 (23.0%)385 (25.0%)427 (19.7%)1032 (23.9%)0.012 4--4.71961 (24.4%)379 (24.6%)524 (24.2%)1058 (24.5%) 4.8--5.21644 (20.5%)363 (23.5%)478 (22.1%)803 (18.6%) 5.2+1590 (19.8%)316 (20.5%)488 (22.5%)786 (18.2%) Missing data984 (12.3%)100 (6.5%)249 (11.5%)635 (14.7%)Pregnancy status Not pregnant7715 (96.2%)1517 (98.3%)2109 (97.4%)4089 (94.8%)\< 0.001 Pregnant30 (0.4%)5 (0.3%)7 (0.3%)18 (0.4%) Missing data278 (3.5%)21 (1.4%)50 (2.3%)207 (4.8%)

The distribution of educational level and occupational status according to gender, mode of HIV transmission and area of residency are shown in Fig. [1](#Fig1){ref-type="fig"}. Women, PWID and residents in Southern Italy presented the lowest levels of education and the highest rate of unemployment compared to other groups.Fig. 1Distribution of education level (**a**) and occupational status (**b**) according to gender, mode of HIV transmission and area of residency

The median CD4 cell count at time of enrolment in the ICONA cohort according to the investigated socio-demographic variables is summarized in Table [2](#Tab2){ref-type="table"} In particular, women, people who acquired the HIV infection through heterosexual contacts, older individuals, and housewives, were more at risk of late presentation. Moreover, the risk of late presentation decreased with increasing educational level.Table 2Median CD4 cell count at time of enrolment in the ICONA cohort and at time of ART initiation according to socio-demographic characteristicsCD4 at enrollmentCD4 at time of ART initiationMedianIQR*p*MedianIQR*p*n/mmcn/mmcn/mmcn/mmcGender Male439260--6210.453360223--520\< 0.001 Female448263--635325205--479Age (years) \< 30511364--696\< 0.001390273--563\< 0.001 30--40440269--622358225--514 40--50377188--554323173--483 \> 50283108--500273105--422Mode of HIV transmission HS385191--580\< 0.001310171--460\< 0.001 PWID482305--685342222--530 MSM471310--643390267--550Residency area North499336--694\< 0.001333232--460\< 0.001 Centre443270--634302193--436 South432248--646330205--516Education Elementary school384179--606\< 0.001288156--430\< 0.001 Junior high school437232--624320197--481 High school438261--613353224--505 University464299--637393272--569Employement Unemployed439264--644\< 0.001342216--523\< 0.001 Full time worker450279--626351225--506 Self employed437249--621351222--510 Temporary employed467320--650340220--506 Student540385--700443325--648 Retired326131--534274121--440 Housewife390157--590302122--427Year of ART initiation/last observation 2002--2006465278--661\< 0.001292185--448\< 0.001 2007--2011385232--554305196--409 2012--2016460270--637414262--574

The number of lost to follow-up patients according to the main study variables is reported in Table [3](#Tab3){ref-type="table"}; female gender, younger age, PWID, low educational level and unemployment were associated with a higher drop-out rate.Table 3Drop-out rate according to socio-demographic characteristicsN° of lost to follow-up*P*Gender Male1373 (20.8%)\< 0.001 Female423 (29.5%)Age at first positive anti-HIV test \< 30797 (30.9%)\< 0.001 30--40566 (21.4%) 40--50258 (15.1%) \> 50168 (15.6%)Mode of HIV transmission HS571 (20.6%)\< 0.001 PWID552 (48.8%) MSM530 (15.0%) other/unknown143 (24.2%)Residency area North929 (20.5%)\< 0.001 Centre560 (20.9%) South307 (38.1%)Education Elementary school141 (39.0%)\< 0.001 Junior high school574 (31.8%) High school484 (18.8%) University129 (14.0%) Missing468 (19.8%)Employment Unemployed755 (21.1%)\< 0.001 Full time worker347 (38.1%) Self employed264 (21.4%) Temporary employed72 (37.5%) Student67 (22.6%) Retired50 (19.5%) Housewife94 (40.3%) other/unknown33 (16.2%) missing data114 (10.1%)

Time to ART initiation {#Sec6}
----------------------

A total of 6214 cohort participants (77.5%) started ART during the study period after a median time to ART initiation of 0.6 years (IQR 0.1--3.7). The median of years from first HIV test and cART initiation decrease over time \[2002--2006 = 3.3 years (0.2--9.4); 2007--2011 = 1.0 years (0.1--3.9); 2012--2016 = 0.2 years (0.1--2.1), *p* \< 0.001\].

Median CD4 cell count levels at time of ART initiation are also showed in Table [2](#Tab2){ref-type="table"}. Females, patients aged \> 50 years, housewife and retired, and people with lower educational levels presented the lowest CD4 count at ART initiation compared to other groups.

Factors associated with the probability of ART initiation by multivariable analysis are reported in Fig. [2](#Fig2){ref-type="fig"}: females vs. males, PWID compared to HS showed a reduced probability of starting therapy. On the other hand, unemployed people and students compared to full time workers, older people, people with higher educational levels, and residents in the Central and Southern area of the country were more likely to initiate ART.Fig. 2Multivariable model of factors associated with time to cART start (adjusted for CD4 count, viral load, pregnancy status, smoking)

Response to ART {#Sec7}
---------------

A total of 5792 patients starting ART during the study period presented at least 1 year of follow-up and were included in the analysis on the response to ART. 5111 (88.2%) cohort participants reached at least one HIV-RNA \< 50 cp/mL. After adjustment for potential confounders, intravenous drug use compared to heterosexual as mode of HIV transmission, unemployment and temporary employment vs full time work, and residency in Southern and Central vs Northern Italy were associated with a lower probability of achieving HIV-RNA suppression. On the contrary, patients with higher educational levels (high school or university, ISCED 2--4) were more likely to reach an undetectable viral load than their counterparts (Fig. [3](#Fig3){ref-type="fig"}).Fig. 3Multivariable model of factors associated with virological response (HIV RNA \< 50) (adjusted for CD4 count, viral load, pregnancy status, smoking)

ART discontinuation {#Sec8}
-------------------

A total of 3079 out of 5792 patients (53%) changed or interrupted first line-regimen during the study period. In Fig. [4](#Fig4){ref-type="fig"}, factors associated with first-line ART discontinuation by multivariable analysis are summarized. MSM presented a higher risk of first-line ART discontinuation along with patients aged 40--50 and more than 50 years vs \< 30, females vs males, unemployed people compared to full time workers. On the contrary, housewives and residents in Central and Southern Italy presented a lower rate of therapy discontinuation than other groups, while no association was observed between educational level and therapy interruption.Fig. 4Multivariable model of factors associated with treatment discontinuation for any causes (adjusted for CD4 count, viral load, pregnancy status, smoking)

Discussion {#Sec9}
==========

Socio-demographic factors are an important cause of health inequalities, even in high income countries adopting universal health care systems \[[@CR5]\]. In Italy, both HIV testing and ART are free of charge for all individuals, independently on disease stage, work conditions or other economical issues. Data from the national health institute demonstrated a satisfactory framework of the HIV treatment cascade in our country, which appears to be very close to WHO targets, showing that in 2014 92% of people diagnosed with HIV were in ART treatment, 87.7% of whom with suppressed HIV viremia \[[@CR6]\]. According to changes in international and national guidelines, which progressively suggested to start ART at higher CD4 count overtime, our data demonstrate that, for patients enrolled in the ICONA cohort, time to ART initiation significantly decreased from more than 3 years in 2002--2006 up to 0.2 years in the last 4 years. In this context, we aimed to evaluate if social determinants do still play a role in access and response to antiretroviral therapy in PLHIV.

Herein, we limited our analysis to native Italian people in order to avoid that confounding factors related to the status of migrant could influence our results, including language barriers and cultural differences. In a previous paper, however, including patients enrolled in the ICONA cohort as well, an increased risk of both delayed access to ART and virological failure was already demonstrated in migrants living with HIV \[[@CR7]\]. Moreover, only patients enrolled in ICONA during a relative recent period (2002--2016) were included in the present study, in order to take into account exclusively modern (and highly potent) antiretroviral regimens.

The results of our analysis clearly evidenced that, even in a country with universal health care coverage as Italy, several social determinants, including female gender, PWID as a risk factor for HIV transmission, low educational level and unemployment, significantly impact both ART access and outcomes. It should be underlined that these variables are also strictly interconnected to each other: in fact, females, PWID and residents in Southern Italy also presented the lowest level of education and the highest rate of unemployment. Although the public health system is freely assured throughout the country since 1978, after a constitutional reform voted in 2001, budget and organization of health services are under regional control. Therefore, many differences in health services may exist among different Italian areas. Based on historical reasons, Northern, Central, and Southern Italy are quite different from an economic and social point of view, with a North-to-South gradient, being in general Northern regions the most industrialized areas of the nation.

First, a risk of late presentation was demonstrated for all the above mentioned categories, which was particularly evident for people aged more than 50 years, which is in line with national and international reports \[[@CR6], [@CR16]\]. Similarly, older patients started ART with significantly lower CD4 cell number compared to younger subjects and, in parallel, they presented significantly longer time to ART initiation since the first anti-HIV positive test. People \> 50 years old had the same mode of HIV acquisition of younger people, but they may be less aware of their HIV status. Moreover, HIV testing is probably less recommended by health care providers in this group than in young adults \[[@CR17]\]. However, old people need to be recognized as a high risk group as they present poorer immunologic response compared with younger patients, with higher mortality rates \[[@CR18]\]. In our study, ART initiation was more likely with increasing age, even after adjustment for CD4 count. No significant association between age and achievement of viremia suppression on ART after 1 year was demonstrated. Older patients were associated with a more recent year of ART initiation, which was conversely associated with lower risk of discontinuation. From the multivariable analysis, however, after adjusting for year of ART initiation, older age was related to a higher risk of therapy discontinuation, probably due to a higher frequency of side effects and co-morbidities in this patient group. The type of drug ART regimen could also be a possible explanation, as older individuals were more frequently on a protease inhibitor-based regimen (42% compared to 25% in patients aged \> 30 years, data not shown).

If female gender is a risk factor for late presentation, delayed therapy initiation and poor ART response is controversial in literature \[[@CR19]--[@CR21]\]. In fact, several aspects might contribute to confound results from different cohorts, also depending on the chosen endpoints \[[@CR19]\]: firstly, early diagnosis of HIV infection in women is favored by screening programs for HIV during pregnancy; secondly, lower HIV-RNA levels have been observed in women compared to males \[[@CR20]\] which could justify better response rates to ART. Finally, regarding the association of gender and mortality for PLHIV, it should be taken into account that women have an overall higher life expectancy compared to men, at least in Western countries. Moreover, in PLHIV, a lower incidence of non-AIDS events in women compared to males has been described \[[@CR22]\]. In our study, after controlling for other variables including pregnancy status and HIV viremia levels, females resulted more at risk of delayed ART initiation and therapy discontinuation, even if no differences in response rates to the first year of ART were evidenced. The status of housewife, however, was not associated with the same endpoints in our analysis; on the contrary, they presented a lower rate of therapy discontinuation. No data regarding this association in literature are available to our knowledge.

Among the different risk group categories for HIV acquisition, as expected, people who inject drugs presented a delay in initiation of ART and inferior virological response to therapy; our results are in agreement with the paper of Lesko et al. \[[@CR13]\] who demonstrated as PWID, even in recent years, spent a significantly larger amount of time not on ART compared with non-PWID or, when on ART, not virally suppressed, thus greatly contributing to HIV transmission. On the contrary, MSM, who became the most represented group in the last years (52%), initiated ART at significantly higher CD4 levels than other risk groups; however, MSM resulted more frequently at risk of ART change / interruption compared to other groups.

The economic status of PLHIV is always hard to be determined. Educational level and occupational status, however, can be considered good proxies of such condition \[[@CR5]\]. We demonstrated that the educational level has a crucial role of in influencing both access and response to ART in our country. This finding extend previous observations in Italy \[[@CR23]\] and in other European countries \[[@CR24]--[@CR26]\], and are in agreement with recent multi-cohort data from the COHERE \[[@CR10], [@CR11]\]. In addition, the relationship between occupational status and ART access and outcomes was also analyzed. Very few studies \[[@CR12], [@CR27]\] have addressed this point to date, as this information is not registered in the most part of the cohorts enrolling HIV patients. In France \[[@CR27]\], a global indicator of social vulnerability including education, employment, and housing stability and comfort, after adjustment for lifestyle factors, psychosocial characteristics (depression, drug using) and known biomedical factors, was associated with mortality in PLHIV. Moreover, unemployment was associated with a reduced sustained virological suppression (e.g. undetectable viral load for ≥6 months) \[[@CR12]\]. In our analysis, unemployment was associated with all three endpoints (a longer time to ART initiation, lower chances to reach a suppressed HIV viremia, and higher risk of discontinuation). It must be underlined that work conditions, although considered an excellent proxy of economic status, may change during patient's life and cannot be considered as an independent variable as a poor health status could also cause job loss. However, as only the first year ART response was investigated in the present study, and the occupational status was registered at entry in the cohort, our results can be considered reliable.

Among lifestyle factors, smoking was not associated with any of the study endpoints in our analysis \[[@CR14]\]. All results were adjusted for smoking and pregnancy status. However, other behavioral and clinical factors, including alcoholism or depression, were not targeted in our analysis but could have indirectly influenced our results. In particular, the inclusion of mental health outcomes as part of the ICONA database in the future would be suitable. A high percentage of missing data regarding educational level could have introduced some biases, representing an important limitation of our study. A major limitation is also the lack of information regarding the presence of transgender people in our cohort. In fact, even if sexual orientation and gender identity should be reported the ICONA database, no transgender cohort participants were registered among patients fulfilling inclusion criteria in our study, which seems to suggest that this information was under-reported by clinicians \[[@CR28], [@CR29]\].

Conclusions {#Sec10}
===========

In conclusions, notwithstanding median time to ART start decreased from 3.3 to 0.2 years from 2002 to 2016, socio-demographic factors still contribute to important disparities in ART initiation, outcome and durability in PLHIV from Italy. Therefore, a deeper evaluation of socio-economic determinants, possibly using a standardized approach, is needed on one side; on the other side, welfare interventions aiming to reduce the social inequality for fragile populations such as PWID, women, old people, patients with low educational level and unemployed, along with migrants, would indirectly improve the cascade of care for PLHIV. Moreover, it should be underlined that relatively few complete national data regarding continuum of care are available in Italy as in other countries, with wide variation in reporting procedures \[[@CR30]\]. Nowadays it becomes more and more important to use consistent and accurate methods for tracking progress towards the achievement of WHO 90--90-90 targets.
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